7703 - Leukemia
Old Code
7703 - Leukemia
New Code
7703 - Leukemia
Old Rating Criterion 1
7703 Effective July 2, 1985 to October 23, 1995
7703 - Leukemia | Rating |
---|---|
An evaluation of 100 percent is granted whenever there is a requirement for intensive treatment such as periodic irradiation or transfusion. An evaluation of 100 percent is also assigned for acute, rapidly progressive anemia with few or brief remissions. | 100 |
An evaluation of 70 percent is assigned for chronic disease following acute attacks with marked departures from normal blood count, and severe impairment of health and asthenia. A higher evaluation of 100 percent is not warranted unless there is evidence of intensive treatment such as periodic irradiation or transfusion. An evaluation of 100 percent is also assigned for acute, rapidly progressive anemia with few or brief remissions. | 70 |
An evaluation of 60 percent is assigned for chronic disease following acute attacks with departures from normal blood count, impairment of health, and severe asthenia. A higher evaluation of 70 percent is not warranted unless there is evidence of chronic disease following acute attacks with marked departures from normal blood count, and severe impairment of health and asthenia. | 60 |
An evaluation of 30 percent is granted whenever there is indication of incipient disease with achlorhydria and changes in blood count. A higher evaluation of 60 percent is not warranted unless the record shows chronic disease following acute attacks with departures from normal blood count, impairment of health, and severe asthenia. | 30 |
Old Rating Criterion 2
7703 Effective October 23, 1995 to December 9, 2018
7703 - Leukemia | Rating |
---|---|
With active disease or during a treatment phase | 100 |
Otherwise rate as anemia (code 7700) or aplastic anemia (code 7716), whichever would result in the greater benefit. | |
Note: The 100 percent rating shall continue beyond the cessation of any surgical, radiation, antineoplastic chemotherapy or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of 38 CFR 3.105(e). |